T. Boucher

Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease.

F. Sacks, R. Pasternak, G. Horowitz, 1990, The American journal of cardiology.

Usefulness of plasma phospholipid N-3 fatty acid levels in predicting dietary fish intake in patients with coronary artery disease.

F. Sacks, R. Pasternak, G. Reis, 1990, The American journal of cardiology.

creatic Adenocarcinoma

S. Mulvihill, M. Firpo, C. Scaife, 2010 .

Changes in total cholesterol and high-density lipoprotein cholesterol in men after coronary artery bypass grafting.

C. McCabe, R. Pasternak, M. Cunningham, 1987, American Journal of Cardiology.

RANDOMISED TRIAL OF FISH OIL FOR PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY

F. Sacks, C. McCabe, D. Baim, 1989, The Lancet.

Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The Harvard Atherosclerosis Reversibility Project Study Group.

P. Stone, F. Sacks, T. Sandor, 1993, American Journal of Cardiology.

Fish Oil Therapy: Indications, Results, and Problems in Clinical Practice

R. Pasternak, G. Reis, T. Boucher, 1987 .